Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000904454-16-001194
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-02 16:42:46
Reporting Period:
2016-04-28
Filing Date:
2016-05-02
Accepted Time:
2016-05-02 16:42:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348649 Colucid Pharmaceuticals Inc. CLCD () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013425 I Jesse Treu C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1024000 C James Blair C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1196863 Nicole Vitullo C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1207786 H Brian Dovey C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1298034 Dp Vi Associates, L.p. C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-28 235 $6.96 3,284 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
  2. As managing members of the sole general partner of Domain Partners VI, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 2,096,137 shares of Common Stock held by Domain Partners VI, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VI, L.P., however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein, and/or that are not actually distributed to him or her.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.95 to $7.29. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote